SCHEMBL20520366

SCHEMBL20520366

O=C1C=Nc2cccc3cccc1c23

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.46
▸ MAPT P10636 5/20 0.46
▸ HTT P42858 3/20 0.46
▸ RECQL P46063 1/20 0.46
▸ PARP1 P09874 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ CES2 O00748 1/20 0.45
▸ BCHE P06276 1/20 0.45
▸ CES1 P23141 1/20 0.45
▸ MCL1 Q07820 1/20 0.45
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ RXFP1 Q9HBX9 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ PABPC1 P11940 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ MPI P34949 1/20 0.44
▸ CACNA1B Q00975 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29409962 0.76 CDC25B (0.42) KDM4EMAPTHTTRECQLALDH1A1
SCHEMBL1497963 0.76 CDC25B (0.42) KDM4EMAPTHTTRECQLALDH1A1
Hydrochloric Acid SCHEMBL10860848 0.74 KMT2A (0.40) KDM4EMAPTHTTRECQLALDH1A1
Potassium SCHEMBL31207020 0.74 KMT2A (0.40) KDM4EMAPTHTTRECQLALDH1A1
Methane SCHEMBL28363844 0.74 KMT2A (0.40) KDM4EMAPTHTTRECQLALDH1A1
Hydrochloric Acid SCHEMBL10863150 0.74 KMT2A (0.40) KDM4EMAPTHTTRECQLALDH1A1
SCHEMBL1381178 0.71 KDM4E (0.48) KDM4EMAPTHTTRECQLPARP1
SCHEMBL29473502 0.70 GRK6 (0.45) KDM4EMAPTHTTRECQLALDH1A1
SCHEMBL2637178 0.70 GRK6 (0.45) KDM4EMAPTHTTRECQLALDH1A1
SCHEMBL14700219 0.69 ALDH1A1 (0.64) KDM4EMAPTHTTRECQLPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200031828-A1 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEROF SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-01-30 — — US claimed
US-10669274-B2 Azaphenalene-3-one derivative, preparation method therefor, and application therof SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-06-02 — — US disclosed
US-10669274-B2 Azaphenalene-3-one derivative, preparation method therefor, and application therof SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-06-02 — — US disclosed
US-10669274-B2 Azaphenalene-3-one derivative, preparation method therefor, and application therof SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-06-02 — — US disclosed
US-20200031828-A1 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEROF SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-01-30 — — US disclosed
US-20200031828-A1 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEROF SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2020-01-30 — — US disclosed
WO-2018177444-A3 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 苏州康润医药有限公司 2018-11-22 — — WO disclosed
WO-2018177444-A2 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 苏州康润医药有限公司 2018-10-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031828-A1 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEROF PARP1, PARP11, PARP8 KDM4E 397/4885MAPT 4136/4885HTT 2785/4885
US-10669274-B2 Azaphenalene-3-one derivative, preparation method therefor, and application therof PARP1, PARP11, PARP8 KDM4E 397/4885MAPT 4136/4885HTT 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback